Royce & Associates’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.25M Buy
374,540
+106,928
+40% +$1.5M 0.05% 451
2025
Q1
$4.19M Buy
+267,612
New +$4.19M 0.05% 471